ticker

Investors Go Back to School

vanya
07 Apr, 2003
New York City

Smart investors have realised that even in times of economic and geopolitical uncertainty, some education industry players offer profits and growth that are hard to find elsewhere.

Celgene: Cruising Towards Profitability

kalina
02 Apr, 2003
New York City

Even as research efforts of most biotechs are stumbling along without success, Celgene has actually widened its cancer-research program and is fast cruising towards profitability.

Weight Watchers Gains from War on Fat

vanya
25 Mar, 2003
New York City

At a time when the war on Iraq is driving stock markets, Weight Watchers is gaining on another one - the war on fat - as Americans spend billions on weight-loss programs & products.

Biotech M&A Activity Rises, FDA Acts Catalyst

kalina
17 Mar, 2003
New York City

The growing number of deals in the biotech arena suggests sector consolidation is finally under way. The FDA's recent publication of a key report is also becoming a major catalyst.

Growth Opportunities in Network Security

vanya
09 Mar, 2003
New York City

Even though several IT markets are declining, investors can still find growth opportunities in the security sector - particularly, in the firewall/VPN segment.

Blood Cancer Drugs Drive IDEC

kalina
03 Mar, 2003
New York City

The shaky economy has pushed all stocks, including biotechs, to face tough times. Yet, IDEC Pharmaceuticals is one company worth betting on in this highly volatile sector.

Fighting Spam

vanya
24 Feb, 2003
New York City

As spam - or unsolicited e-mail - continues to plague corporate networks, the army of vendors offering defences is growing as well. Will fighting spam become big business?

Biotechs on the Mend; Biogen Triumphs

kalina
16 Feb, 2003
New York City

Despite the many uncertainties associated with the biotech sector, there are several worthy investment choices. Biogen, which got two regulatory approvals lately, is one of them.

Will 2003 Bring an Uptick in the VC Business?

vanya
10 Feb, 2003
New York City

Last year was a sobering one for venture capitalists as investment activity finished at a pace that was the slowest in nearly five years. Will 2003 be better for the VC business?

Johnson & Johnson: Quality at Good Price

kalina
03 Feb, 2003
New York City

Having managed to grow even during an economic slowdown, healthcare and pharma industry top dog Johnson & Johnson, is poised to attain greater heights in the long run.

Business Intelligence Gathers Momentum

vanya
27 Jan, 2003
New York City

Investors have become skittish about software makers, but it might be smart to keep an eye on business intelligence

JP Morgan Meet Puts Biotechs in the Spotlight

kalina
20 Jan, 2003
New York City

The JP Morgan Healthcare meet did little to boost sector stocks, which were already negatively impacted by a slew of bad news. But the market climate is likely to get better soon.

When Will Nanotech Bring in the Big Bucks?

vanya
14 Jan, 2003
New York City

Nanotechnology has recently emerged as one of the most hotly debated topics around the globe. But, is the

Biotechs: A Bleak 2002; Will 2003 Be Better?

kalina
09 Jan, 2003
New York City

After a dismal 2001, biotech stocks ended 2002 on a much weaker note. Still, industry fundamentals seem to be improving and some stocks may give patient investors reasons to cheer

2002 IPO Crop Thin, but Outperforms Market

vanya
30 Dec, 2002
New York City

Although the bleak environment of the broader market in 2002 extended to the IPO arena too, there still was good news for investors as new issues outperformed the market as a whole

Market Update